Immunology and Microbiology
Amino Terminal Sequence
11%
Antibody Response
11%
Antibody Titer
6%
Antiviral Activity
5%
Autoimmunity
5%
Cell Surface
10%
COVID-19
23%
Ebola Virus
11%
Epitope
11%
Glycoprotein
23%
Haplotype
11%
Human Immunodeficiency Virus 1
33%
Immune Escape
5%
Immunoglobulin A
5%
Immunoglobulin M
5%
Infection
11%
Influenzavirus A
11%
Interferon Alfa
11%
Interferon Type I
47%
Leukocyte
5%
Macrophage
14%
Monoclonal Antibody
17%
Myeloid
10%
Neutralization
17%
Neutralizing Antibody
31%
Programmed Death-Ligand 1
11%
Protein Tertiary Structure
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Real-Time Polymerase Chain Reaction
6%
Receptor Binding
22%
Revertant
5%
RNA Extraction
8%
RNA Virus
5%
SARS Coronavirus
23%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Spike
78%
Sterile Alpha Motif
11%
Tetherin
25%
Viral Replication
6%
Virion
11%
Virus
25%
Virus Genome
5%
Virus Infectivity
7%
Vpx
5%
Xenotropic MuLV Related Virus
11%
Medicine and Dentistry
Antiviral Protein
11%
COVID-19
43%
Dinucleotide
11%
Diseases
6%
Emergency Department
11%
Enzyme Linked Immunosorbent Assay
7%
Human Immunodeficiency Virus
12%
Immunoassay
25%
Infection
29%
Infection Control
6%
Lateral Flow Assay
11%
Post-COVID-19
11%
Public Health
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Reverse Transcription Polymerase Chain Reaction
7%
Severe Acute Respiratory Syndrome Coronavirus 2
88%
Virus
7%
Virus Nucleocapsid
7%
Virus RNA
8%
Xenotropic MuLV Related Virus
11%
Zinc Finger Protein
11%
Biochemistry, Genetics and Molecular Biology
Antiviral Protein
13%
Human Immunodeficiency Virus 1
22%
Janus Kinase 1
11%
RNA
16%
SARS Coronavirus
11%
Tetherin
25%
Virion
9%
Xenotropic MuLV Related Virus
11%
